United States Biotechnology & Medical Research

Cartesian Therapeutics Inc (RNAC)

Track

Over the past 90 days, Cartesian Therapeutics Inc. recorded two insider transactions, both involving proposed sales by a former affiliate totaling approximately $257,879. These transactions follow the company's most recent earnings report, which showed an EPS miss of 35.7%. The stock has experienced an 11.1% price increase over the same period.
Ticker: RNAC Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Cartesian Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Proposed sale 9 Jun 2026
Value US$2,476,026.12 | Price 455.52 | Shares 32,994
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-09 2026-06-09 PrS Proposed sale
2.2
MILOS MILJKOVIC

Former Affiliate
32,994
455.52
US$2,476,026 		32,994 455.52 US$2,476,026
2026-06-02 2026-06-02 PrS Proposed sale
2.2
MILOS MILJKOVIC

Former Affiliate
96,165
25.83
US$127,551 		96,165 25.83 US$127,551
2026-01-13 2026-01-13 PrS Proposed sale
1.9
CHRISTOPHER M JEWELL

Former Affiliate
22,935
323.78
US$3,356,299 		22,935 323.78 US$3,356,299
2026-01-09 2026-01-09 PrS Proposed sale
1.9
CHRISTOPHER M JEWELL

Former Affiliate
1,510
8.02
US$12,105 		1,510 8.02 US$12,105
2026-01-08 2026-01-06 S Sale
3.7
Brunn Carsten

President and CEO

Executive Director
23,766 -6.8%
6.82
US$162,077 		23,766 -6.8% 6.82 US$162,077
2026-01-08 2026-01-06 S Sale
2.2
Miljkovic Milos

Chief Medical Officer

Officer
3,573 -5.7%
6.82
US$24,367 		3,573 -5.7% 6.82 US$24,367
2026-01-08 2026-01-06 S Sale
3.2
Davis Blaine

Chief Financial Officer

Officer
10,591 -8.0%
6.82
US$72,227 		10,591 -8.0% 6.82 US$72,227
2025-12-08 2025-12-04 B Purchase
2.3
BARABE TIMOTHY C
Non-Executive Director
30,000 +123.1%
6.86
US$205,797 		30,000 +123.1% 6.86 US$205,797
2025-11-19 2025-11-19 PrS Proposed sale
1.9
CHRISTOPHER M JEWELL

Former Affiliate
26,935
7.15
US$192,585 		26,935 7.15 US$192,585
2025-04-11 2025-04-11 B Purchase
3.4
SPRINGER TIMOTHY A
Non-Executive Director Large shareholder
36,338 +5.9%
10.77
US$391,455 		36,338 +5.9% 10.77 US$391,455
2025-04-11 2025-04-11 B Purchase
3.4
SPRINGER TIMOTHY A
Non-Executive Director Large shareholder
6,412 +0.1%
10.77
US$69,074 		6,412 +0.1% 10.77 US$69,074
2025-04-11 2025-04-10 B Purchase
3.4
SPRINGER TIMOTHY A
Non-Executive Director Large shareholder
3,451 +0.6%
10.92
US$37,696 		3,451 +0.6% 10.92 US$37,696
2025-04-11 2025-04-10 B Purchase
3.4
SPRINGER TIMOTHY A
Non-Executive Director Large shareholder
45,144 +7.9%
10.43
US$471,055 		45,144 +7.9% 10.43 US$471,055
2025-04-11 2025-04-10 B Purchase
3.4
SPRINGER TIMOTHY A
Non-Executive Director Large shareholder
609 +0.0%
10.92
US$6,652 		609 +0.0% 10.92 US$6,652
2025-04-11 2025-04-10 B Purchase
3.4
SPRINGER TIMOTHY A
Non-Executive Director Large shareholder
7,966 +0.1%
10.43
US$83,121 		7,966 +0.1% 10.43 US$83,121
2025-04-11 2025-04-09 B Purchase
3.4
SPRINGER TIMOTHY A
Non-Executive Director Large shareholder
178 +0.0%
9.95
US$1,771 		178 +0.0% 9.95 US$1,771
2025-04-11 2025-04-09 B Purchase
3.4
SPRINGER TIMOTHY A
Non-Executive Director Large shareholder
41,604 +7.9%
9.43
US$392,176 		41,604 +7.9% 9.43 US$392,176
2025-04-11 2025-04-09 B Purchase
3.4
SPRINGER TIMOTHY A
Non-Executive Director Large shareholder
31 +0.0%
9.95
US$308 		31 +0.0% 9.95 US$308
2025-04-11 2025-04-09 B Purchase
3.4
SPRINGER TIMOTHY A
Non-Executive Director Large shareholder
7,342 +0.1%
9.43
US$69,209 		7,342 +0.1% 9.43 US$69,209
2025-03-20 2025-03-20 B Purchase
3.4
SPRINGER TIMOTHY A
Non-Executive Director Large shareholder
54,889 +0.6%
15.59
US$855,593 		54,889 +0.6% 15.59 US$855,593
2025-03-20 2025-03-19 B Purchase
3.4
SPRINGER TIMOTHY A
Non-Executive Director Large shareholder
20,234 +0.2%
14.97
US$302,962 		20,234 +0.2% 14.97 US$302,962
2025-03-20 2025-03-18 B Purchase
3.4
SPRINGER TIMOTHY A
Non-Executive Director Large shareholder
14,740 +0.2%
14.42
US$212,599 		14,740 +0.2% 14.42 US$212,599
2025-01-15 2025-01-14 B Purchase
3.4
SPRINGER TIMOTHY A
Non-Executive Director Large shareholder
4,022 +0.0%
18.00
US$72,396 		4,022 +0.0% 18.00 US$72,396
2025-01-15 2025-01-13 B Purchase
3.4
SPRINGER TIMOTHY A
Non-Executive Director Large shareholder
8,983 +0.1%
17.78
US$159,738 		8,983 +0.1% 17.78 US$159,738
2025-01-15 2025-01-13 B Purchase
3.4
SPRINGER TIMOTHY A
Non-Executive Director Large shareholder
7,962 +0.1%
16.86
US$134,220 		7,962 +0.1% 16.86 US$134,220
2025-01-07 2025-01-06 S Sale
2.7
Kurtoglu Metin

Chief Technology Officer

Officer
2,458 -3.8%
16.83
US$41,374 		2,458 -3.8% 16.83 US$41,374
2025-01-07 2025-01-06 S Sale
3.2
Davis Blaine

Chief Financial Officer

Officer
4,028 -4.1%
16.83
US$67,800 		4,028 -4.1% 16.83 US$67,800
2025-01-07 2025-01-06 S Sale
2.2
Miljkovic Milos

Chief Medical Officer

Officer
948 -2.6%
16.83
US$15,957 		948 -2.6% 16.83 US$15,957
2025-01-07 2025-01-06 S Sale
1.9
Jewell Christopher M

Chief Scientific Officer

Officer
1,286 -2.3%
16.83
US$21,646 		1,286 -2.3% 16.83 US$21,646
2025-01-07 2025-01-06 S Sale
3.7
Brunn Carsten

President and CEO

Executive Director
8,708 -4.1%
16.83
US$146,575 		8,708 -4.1% 16.83 US$146,575
2025-01-07 2025-01-06 S Sale
2.7
English Emily

Chief Operations Officer

Officer
906 -2.2%
16.83
US$15,250 		906 -2.2% 16.83 US$15,250
2025-01-07 2025-01-03 S Sale
2.7
Kurtoglu Metin

Chief Technology Officer

Officer
2,417 -3.6%
16.72
US$40,417 		2,417 -3.6% 16.72 US$40,417
2025-01-07 2025-01-03 S Sale
3.2
Davis Blaine

Chief Financial Officer

Officer
3,961 -3.9%
16.72
US$66,235 		3,961 -3.9% 16.72 US$66,235
2025-01-07 2025-01-03 S Sale
2.2
Miljkovic Milos

Chief Medical Officer

Officer
932 -2.5%
16.72
US$15,585 		932 -2.5% 16.72 US$15,585
2025-01-07 2025-01-03 S Sale
1.9
Jewell Christopher M

Chief Scientific Officer

Officer
1,264 -2.3%
16.72
US$21,136 		1,264 -2.3% 16.72 US$21,136
2025-01-07 2025-01-03 S Sale
3.7
Brunn Carsten

President and CEO

Executive Director
8,563 -3.9%
16.72
US$143,190 		8,563 -3.9% 16.72 US$143,190
2025-01-07 2025-01-03 S Sale
2.7
English Emily

Chief Operations Officer

Officer
891 -2.1%
16.72
US$14,899 		891 -2.1% 16.72 US$14,899
2024-12-23 2024-12-23 B Purchase
3.4
SPRINGER TIMOTHY A
Non-Executive Director Large shareholder
5,181 +0.1%
19.00
US$98,437 		5,181 +0.1% 19.00 US$98,437
2024-12-23 2024-12-20 B Purchase
3.4
SPRINGER TIMOTHY A
Non-Executive Director Large shareholder
21,800 +0.3%
18.94
US$412,968 		21,800 +0.3% 18.94 US$412,968
2024-12-23 2024-12-19 B Purchase
3.4
SPRINGER TIMOTHY A
Non-Executive Director Large shareholder
3,376 +0.0%
18.93
US$63,901 		3,376 +0.0% 18.93 US$63,901
2024-12-23 2024-12-19 B Purchase
3.4
SPRINGER TIMOTHY A
Non-Executive Director Large shareholder
10,529 +0.1%
18.35
US$193,203 		10,529 +0.1% 18.35 US$193,203
2024-12-23 2024-12-19 B Purchase
3.4
SPRINGER TIMOTHY A
Non-Executive Director Large shareholder
11,303 +0.1%
17.39
US$196,512 		11,303 +0.1% 17.39 US$196,512
2024-12-11 2024-12-10 S Sale
2.7
Kurtoglu Metin

Chief Technology Officer

Officer
2,901 -5.4%
24.35
US$70,640 		2,901 -5.4% 24.35 US$70,640
2024-12-10 2024-12-10 PrS Proposed sale
2.7
METIN KURTOGLU

Officer

Officer
2,901
24.35
US$70,640 		2,901 24.35 US$70,640
2024-12-11 2024-12-09 S Sale
2.7
Kurtoglu Metin

Chief Technology Officer

Officer
4,539 -8.2%
25.83
US$117,257 		4,539 -8.2% 25.83 US$117,257
2024-12-11 2024-12-09 S Sale
2.7
Kurtoglu Metin

Chief Technology Officer

Officer
6,224 -10.1%
25.26
US$157,236 		6,224 -10.1% 25.26 US$157,236
2024-12-09 2024-12-09 PrS Proposed sale
2.7
METIN KURTOGLU

Officer

Officer
10,763
25.50
US$274,493 		10,763 25.50 US$274,493
2024-11-21 2024-11-21 PrS Proposed sale
2.7
METIN KURTOGLU

Officer

Officer
32,789
16.67
US$546,560 		32,789 16.67 US$546,560
2024-11-21 2024-11-21 S Sale
2.7
Kurtoglu Metin

Chief Technology Officer

Officer
32,789 -39.1%
16.67
US$546,560 		32,789 -39.1% 16.67 US$546,560
2024-11-21 2024-11-20 S Sale
2.7
Kurtoglu Metin

Chief Technology Officer

Officer
100 -0.2%
18.09
US$1,809 		100 -0.2% 18.09 US$1,809
2024-11-21 2024-11-20 S Sale
2.7
Kurtoglu Metin

Chief Technology Officer

Officer
5,600 -9.9%
17.28
US$96,761 		5,600 -9.9% 17.28 US$96,761
2024-11-20 2024-11-20 PrS Proposed sale
2.7
METIN KURTOGLU

Officer

Officer
5,700
17.29
US$98,570 		5,700 17.29 US$98,570
2024-11-21 2024-11-19 S Sale
2.7
Kurtoglu Metin

Chief Technology Officer

Officer
200 -0.4%
19.50
US$3,900 		200 -0.4% 19.50 US$3,900
2024-11-19 2024-11-19 PrS Proposed sale
2.7
METIN KURTOGLU

Officer

Officer
200
19.50
US$3,900 		200 19.50 US$3,900
2024-11-18 2024-11-18 PrS Proposed sale
2.7
METIN KURTOGLU

Officer

Officer
34,400
18.39
US$632,640 		34,400 18.39 US$632,640
2024-11-18 2024-11-18 S Sale
2.7
Kurtoglu Metin

Chief Technology Officer

Officer
17,728 -25.8%
18.58
US$329,429 		17,728 -25.8% 18.58 US$329,429
2024-11-18 2024-11-18 S Sale
2.7
Kurtoglu Metin

Chief Technology Officer

Officer
16,672 -19.5%
18.19
US$303,212 		16,672 -19.5% 18.19 US$303,212
2024-11-18 2024-11-18 B Purchase
3.4
SPRINGER TIMOTHY A
Non-Executive Director Large shareholder
20,181 +0.2%
18.42
US$371,736 		20,181 +0.2% 18.42 US$371,736
2024-11-18 2024-11-18 B Purchase
3.4
SPRINGER TIMOTHY A
Non-Executive Director Large shareholder
38,114 +0.5%
17.96
US$684,447 		38,114 +0.5% 17.96 US$684,447
2024-11-18 2024-11-15 S Sale
2.2
Miljkovic Milos

Chief Medical Officer

Officer
20,000 -52.3%
17.14
US$342,888 		20,000 -52.3% 17.14 US$342,888
2024-11-18 2024-11-15 S Sale
2.7
Kurtoglu Metin

Chief Technology Officer

Officer
22,068 -30.2%
17.20
US$379,497 		22,068 -30.2% 17.20 US$379,497
2024-11-18 2024-11-15 S Sale
1.9
Jewell Christopher M

Chief Scientific Officer

Officer
16,065 -38.2%
17.06
US$274,093 		16,065 -38.2% 17.06 US$274,093
2024-11-18 2024-11-15 B Purchase
3.4
SPRINGER TIMOTHY A
Non-Executive Director Large shareholder
277,246 +3.4%
17.09
US$4,739,188 		277,246 +3.4% 17.09 US$4,739,188
2024-11-15 2024-11-15 PrS Proposed sale
2.7
METIN KURTOGLU

Officer

Officer
22,068
17.20
US$379,497 		22,068 17.20 US$379,497
2024-11-15 2024-11-15 PrS Proposed sale
1.9
CHRISTOPHER M JEWELL

Officer

Officer
16,065
17.06
US$274,093 		16,065 17.06 US$274,093
2024-11-15 2024-11-15 PrS Proposed sale
2.2
MILOS MILJKOVIC

Officer

Officer
20,000
17.14
US$342,889 		20,000 17.14 US$342,889
2024-11-18 2024-11-14 S Sale
2.2
Miljkovic Milos

Chief Medical Officer

Officer
35,000 -65.7%
16.13
US$564,644 		35,000 -65.7% 16.13 US$564,644
2024-11-18 2024-11-14 S Sale
2.7
Kurtoglu Metin

Chief Technology Officer

Officer
4,000 -7.3%
17.06
US$68,256 		4,000 -7.3% 17.06 US$68,256
2024-11-18 2024-11-14 S Sale
2.7
Kurtoglu Metin

Chief Technology Officer

Officer
21,900 -28.5%
16.33
US$357,645 		21,900 -28.5% 16.33 US$357,645
2024-11-18 2024-11-14 S Sale
1.9
Jewell Christopher M

Chief Scientific Officer

Officer
17,500 -40.3%
17.02
US$297,824 		17,500 -40.3% 17.02 US$297,824
2024-11-18 2024-11-14 S Sale
1.9
Jewell Christopher M

Chief Scientific Officer

Officer
18,550 -29.9%
16.34
US$303,126 		18,550 -29.9% 16.34 US$303,126
2024-11-18 2024-11-14 B Purchase
3.4
SPRINGER TIMOTHY A
Non-Executive Director Large shareholder
22,242 +0.3%
16.97
US$377,436 		22,242 +0.3% 16.97 US$377,436
2024-11-18 2024-11-14 B Purchase
3.4
SPRINGER TIMOTHY A
Non-Executive Director Large shareholder
74,157 +0.9%
16.19
US$1,200,720 		74,157 +0.9% 16.19 US$1,200,720
2024-11-14 2024-11-14 PrS Proposed sale
2.7
METIN KURTOGLU

Officer

Officer
25,900
16.44
US$425,900 		25,900 16.44 US$425,900
2024-11-14 2024-11-14 PrS Proposed sale
1.9
CHRISTOPHER M JEWELL

Officer

Officer
36,050
16.67
US$600,949 		36,050 16.67 US$600,949
Explore more

More insider trading research around Cartesian Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America